Search - tctmd.com

Displaying 961 - 980 of 990

Sort: Relevancy | Date

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

STEMI Patient Population Evolves Over 15 Years

Yael L. Maxwell

August 27, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Daily News

Stopping Clopidogrel 1 Year After MI Raises Risk in PCI Patients

Jason Kahn

July 20, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Daily News

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

June 05, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Daily News

Acute Kidney Injury Incidence Down in AMI Patients Despite High Risk Factors

March 23, 2012

News Daily News

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Caitlin E. Cox

March 12, 2012

News Daily News

Study Shines Spotlight on US Readmissions After STEMI

Yael L. Maxwell

January 04, 2012

News Daily News

Hospital Readmission Post-PCI Linked to Increased Mortality

Yael L. Maxwell

December 05, 2011

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Daily News

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

October 26, 2011

News Daily News

Study Proposes New CK-MB Threshold for Periprocedural MI

Caitlin E. Cox

October 12, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Daily News

Postconditioning Again Fails to Reduce Reperfusion Injury After STEMI

August 24, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

August 01, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

Advertisement

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

STEMI Patient Population Evolves Over 15 Years

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Stopping Clopidogrel 1 Year After MI Raises Risk in PCI Patients

More Than Half of Readmissions Within 30 Days of Acute MI Unrelated to Index Event

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Acute Kidney Injury Incidence Down in AMI Patients Despite High Risk Factors

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Study Shines Spotlight on US Readmissions After STEMI

Hospital Readmission Post-PCI Linked to Increased Mortality

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

Study Proposes New CK-MB Threshold for Periprocedural MI

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Postconditioning Again Fails to Reduce Reperfusion Injury After STEMI

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

Ticagrelor Gains FDA Approval for Use in ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content